8-KThe WireRoutine
Shareholder Vote
Filed Jun 5, 2026 · 25d ago · Accession 0001628280-26-041298
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Vanda Pharmaceuticals Inc.
- Ticker
- VNDA
- CIK
- 1347178
- Form type
- 8-K
- Filing date
- Jun 5, 2026
- Report date
- Jun 4, 2026
- Document
- vnda-20260604.htm
- Size
- 163 KB